Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results | The Manila Times

ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026.